Abstract
The immunomodulatory adjuvant and antihelminth levamisole is increasingly used as an adulterant in cocaine worldwide. An accumulating body of clinical and toxicological literature has appeared since 2010 describing neutropenia, agranulocytosis, leukoencephalopathy and vasculitis in cases associated with levamisole-adulterated cocaine. Mostly, neutropenia and agranulocytosis were reported, characterized by a decimation of neutrophils. A large proportion of cases also involved vasculopathy, characterized by pronounced black and purple skin purpura with cutaneous necrosis. Females are more susceptible for both agranulocytosis and vasculitis. Another complication reported with levamisole-adulterated cocaine is leukoencephalopathy, a disabling and potentially fatal neurological disorder caused by cerebral demyelination. In this review, all adverse effects associated with therapeutic levamisole and levamisole-adulterated cocaine are described. In addition, this review provides an update of the pharmacology of levamisole, its metabolism, including toxic metabolites and metabolites that are relevant for levamisole’s addition to cocaine. Special emphasis is put on the immunopathology and the dose–effect relationship of chronic levamisole exposure. Finally, a risk assessment is provided based on the current level of levamisole adulteration in street cocaine, the dose range calculated per gram and the pattern of chronic exposure in heavy or dependent users.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Agarwal A, Shukla OP, Ghatak S, Tekwani BL (1990) Biogenic amines, metabolites and monoamine oxidase in the filarial worm Setaria cervi. Int J Parasitol 20:873–881. doi:10.1016/0020-7519(90)90025-I
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders. American Psychiatric Association Publishing, Arlington, VA
Amery WKP, Bruynseels JPJM (1992) Levamisole, the story and the lessons. Int J Immunopharmacol 14:481–486. doi:10.1016/0192-0561(92)90179-O
Amery WK, Butterworth BS (1983) The dosage regimen of levamisole in cancer: is it related to efficacy and safety? Int J Immunopharmacol 5:1–9
Ammar AT, Livak M, Witsil JC et al (2015) Old drug new trick: levamisole-adulterated cocaine causing acute kidney injury. Am J Emerg Med 33(309):e3–e4. doi:10.1016/j.ajem.2014.08.015
Arora NP (2013) Cutaneous vasculopathy and neutropenia associated with levamisole-adulterated cocaine. Am J Med Sci 345:45–51. doi:10.1097/MAJ.0b013e31825b2b50
Barker SA (2009) The formation of aminorex in racehorses following levamisole administration. A quantitative and chiral analysis following synthetic aminorex or levamisole administration vs. aminorex-positive samples from the field: a preliminary report. J Vet Pharmacol Ther 32:160–166. doi:10.1111/j.1365-2885.2008.01015.x
Bertol E, Mari F, Milia MG Di et al (2011) Determination of aminorex in human urine samples by GC–MS after use of levamisole. J Pharm Biomed Anal 55:1186–1189. doi:10.1016/j.jpba.2011.03.039
Bharadwaj M, Illing P, Theodossis A et al (2012) Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex. Annu Rev Pharmacol Toxicol 52:401–431. doi:10.1146/annurevpharmtox-010611-134701
Brabant W, Mazure D, Vantilborgh A et al (2012) Agranulocytosis after cocaine use: a case of suspected levamisole contamination in Belgium. Clin Neurol Neurosurg 114:1159–1160. doi:10.1016/j.clineuro.2011.12.012
Bradford M, Rosenberg B, Moreno J, Dumyati G (2010) Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole. Ann Intern Med 152:758–759. doi:10.7326/0003-4819-152-11-201006010-00026
Brunt TM, Rigter S, Hoek J et al (2009) An analysis of cocaine powder in the Netherlands: content and health hazards due to adulterants. Addiction 104:798–805. doi:10.1111/j.1360-0443.2009.02532.x
Buchanan JA, Oyer RJ, Patel NR et al (2010) A confirmed case of agranulocytosis after use of cocaine contaminated with levamisole. J Med Toxicol 6:160–164. doi:10.1007/s13181-010-0060-3
Buchanan JA, Heard K, Burbach C et al (2011) Prevalence of levamisole in urine toxicology screens positive for cocaine in an inner-city hospital. JAMA 305:1657–1658. doi:10.1001/jama.2011.531
Casale JF, Boudreau DK, Jones LM (2008) Tropane ethyl esters in illicit cocaine: isolation, detection, and determination of new manufacturing by-products from the clandestine purification of crude cocaine base with ethanol. J Forensic Sci 53:661–667. doi:10.1111/j.1556-4029.2008.00698.x
Casale JF, Colley VL, Legatt DF (2012) Determination of phenyltetrahydroimidazothiazole enantiomers (Levamisole/Dexamisole) in illicit cocaine seizures and in the urine of cocaine abusers via chiral capillary gas chromatography-flame-ionization detection: clinical and forensic perspectives. J Anal Toxicol 36:130–135. doi:10.1093/jat/bkr025
Chang A, Osterloh J, Thomas J (2010) Levamisole: a dangerous new cocaine adulterant. Clin Pharmacol Ther 88:408–411. doi:10.1038/clpt.2010.156
Chastel C, Mabin D (1996) Encephalopathies after levamisole therapy. Neurology 46:288
Ching JA, Smith DJ Levamisole-induced necrosis of skin, soft tissue, and bone: case report and review of literature. J Burn Care Res 33:e1–5. doi:10.1097/BCR.0b013e318233fc64
Chrisp P, McTavish D (1991) Levamisole/fluorouracil. Drugs Aging 1:317–337. doi:10.2165/00002512-199101040-00007
Chung C, Tumeh PC, Birnbaum R et al (2011) Characteristic purpura of the ears, vasculitis, and neutropenia—a potential public health epidemic associated with levamisole-adulterated cocaine. J Am Acad Dermatol 65(722–725):e2. doi:10.1016/j.jaad.2010.08.024
Cooper KM, Whelan M, Danaher M, Kennedy DG (2011) Stability during cooking of anthelmintic veterinary drug residues in beef. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 28:155–165. doi:10.1080/19440049.2010.542775
Cossaart N, SantaCruz KS, Preston D et al (2003) Fatal chemotherapy-induced encephalopathy following high-dose therapy for metastatic breast cancer: a case report and review of the literature. Bone Marrow Transpl 31:57–60. doi:10.1038/sj.bmt.1703768
Crossley R (1995) Chirality and the biological activity of drugs. Taylor & Francis Group, Abingdon, UK
Fassas AB, Gattani AM, Morgello S (1994) Cerebral demyelination with 5-fluorouracil and levamisole. Cancer Invest 12:379–383
Figueredo AT, Fawcet SE, Molloy DW et al (1995) Disabling encephalopathy during 5-fluorouracil and levamisole adjuvant therapy for resected colorectal cancer: a report of two cases. Cancer Invest 13:608–611
Freyer CW, Peters M (2012) Palpable purpura complicated by streptococcal toxic shock syndrome resulting in limb necrosis and amputation: a case of levamisole and cocaine coingestion. Pharmacother J Hum Pharmacol Drug Ther 32:e17–e23. doi:10.1002/PHAR.1012
Fucci N, Anonymous, Valentino AM et al (2007) Unusual adulterants in cocaine seized on Italian clandestine market. Forensic Sci Int 172:e1. doi:10.1016/j.forsciint.2007.05.021
Gaertner EM, Switlyk SA (2014) Dermatologic complications from levamisole-contaminated cocaine: a case report and review of the literature. Cutis 93:102–106
Gertner E, Hamlar D (2002) Necrotizing granulomatous vasculitis associated with cocaine use. J Rheumatol 29:1795–1797
González-Duarte A, Williams R (2013) Cocaine-induced recurrent leukoencephalopathy. Neuroradiol J 26:511–513
Graf J, Lynch K, Yeh C-L et al (2011) Purpura, cutaneous necrosis, and antineutrophil cytoplasmic antibodies associated with levamisole-adulterated cocaine. Arthritis Rheum 63:3998–4001. doi:10.1002/art.30590
Gulati S, Donato AA (2012) Lupus anticoagulant and ANCA associated thrombotic vasculopathy due to cocaine contaminated with levamisole: a case report and review of the literature. J Thromb Thrombolysis 34:7–10. doi:10.1007/s11239-012-0711-0
Hantson P, Di Fazio V, Del Mar Ramirez Fernandez M et al (2015) Susac-like syndrome in a chronic cocaine abuser: could levamisole play a role? J Med Toxicol 11:124–128. doi:10.1007/s13181-014-0422-3
Hernando G, Berge I, Rayes D, Bouzat C (2012) Contribution of subunits to caenorhabditis elegans levamisole-sensitive nicotinic receptor function. Mol Pharmacol 82:550–560. doi:10.1124/mol.112.079962
Hess C, Ritke N, Broecker S et al (2013) Metabolism of levamisole and kinetics of levamisole and aminorex in urine by means of LC-QTOF-HRMS and LC-QqQ-MS. Anal Bioanal Chem 405:4077–4088. doi:10.1007/s00216-013-6829-x
Hess C, Ritke N, Sydow K et al (2014) Determination of levamisole, aminorex, and pemoline in plasma by means of liquid chromatography-mass spectrometry and application to a pharmacokinetic study of levamisole. Drug Test Anal 6:1049–1054. doi:10.1002/dta0.1619
Hodinka L, Géher P, Merétey K et al (1981) Levamisole-induced neutropenia and agranulocytosis: association with HLA B27 leukocyte agglutinating and lymphocytotoxic antibodies. Int Arch Allergy Appl Immunol 65:460–464
Hofmaier T, Luf A, Seddik A et al (2014) Aminorex, a metabolite of the cocaine adulterant levamisole, exerts amphetamine like actions at monoamine transporters. Neurochem Int 73:32–41. doi:10.1016/j.neuint.2013.11.010
Hook CC, Kimmel DW, Kvols LK et al (1992) Multifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisole. Ann Neurol 31:262–267. doi:10.1002/ana.410310306
Indorato F, Romano G, Barbera N et al (2016) Levamisole-adulterated cocaine: two fatal case reports and evaluation of possible cocaine toxicity potentiation. Forensic Sci Int 265:103–106. doi:10.1016/j.forsciint.2016.01.005
Karch SB, Defraia B, Messerini L et al (2014) Aminorex associated with possible idiopathic pulmonary hypertension in a cocaine user. Forensic Sci Int 240:e7–e10. doi:10.1016/j.forsciint.2014.03.028
Kimmel DW, Wijdicks EF, Rodriguez M (1995) Multifocal inflammatory leukoencephalopathy associated with levamisole therapy. Neurology 45:374–376
Knowles L, Buxton JA, Skuridina N et al (2009) Levamisole tainted cocaine causing severe neutropenia in Alberta and British Columbia. Harm Reduct J 6:30. doi:10.1186/1477-7517-6-30
Kouassi E, Caillé G, Léry L et al (1986) Novel assay and pharmacokinetics of levamisole andp-hydroxylevamisole in human plasma and urine. Biopharm Drug Dispos 7:71–89. doi:10.1002/bdd.2510070110
Larocque A, Hoffman RS (2012) Levamisole in cocaine: unexpected news from an old acquaintance. Clin Toxicol (Phila) 50:231–241. doi:10.3109/15563650.2012.665455
Liu HM, Hsieh WJ, Yang CC et al (2006) Leukoencephalopathy induced by levamisole alone for the treatment of recurrent aphthous ulcers. Neurology 67:1065–1067. doi:10.1212/01.wnl.0000237344.06122.79
Long L, Song Y, Xu L, Xiao B (2015) Levamisole-induced leukoencephalopathy mimicking Baló disease. Neurology 84:328. doi:10.1212/WNL.0000000000001150
Luppi G, Zoboli A, Barbieri F et al (1996) Multifocal leukoencephalopathy associated with 5-fluorouracil and levamisole adjuvant therapy for colon cancer. A report of two cases and review of the literature. Ann Oncol 7:412–415. doi:10.1093/oxfordjournals.annonc.a010610
Luyckx M, Rousseau F, Cazin M et al (1982) Pharmacokinetics of Levamisole in healthy subjects and cancer patients. Eur J Drug Metab Pharmacokinet 7:247–254. doi:10.1007/BF03189626
Marinelli MA, McGhee J (2012) Clinical pathologic conference: a 51-year-old man with rash and joint pain. Acad Emerg Med 19:e41–e44. doi:10.1111/j.1553-2712.2012.01398.x
Martinez-Cabriales S, Ocampo-Garza J, Barbosa-Moreno L, et al (2015) Purpura fulminans 10 years after contaminated cocaine use. Lancet (London, England) 386:e21. doi:10.1016/S0140-6736(15)60069-1
McGrath MM, Isakova T, Rennke HG et al (2011) Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. Clin J Am Soc Nephrol 6:2799–2805. doi:10.2215/CJN.03440411
Metwally O, Hamidi M, Townsend L et al (2013) The cocaine trail: levamisole-induced leukocytoclastic vasculitis in a cocaine user. Subst Abus 34:75–77. doi:10.1080/08897077.2012.718318
Moertel CG, Fleming TR, Macdonald JS et al (1990) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352–358. doi:10.1056/NEJM199002083220602
Muirhead TT, Eide MJ (2011) Images in clinical medicine. Toxic effects of levamisole in a cocaine user. N Engl J Med 364:e52. doi:10.1056/NEJMicm1008722
Orriols R, Muñoz X, Ferrer J et al (1996) Cocaine-induced Churg-Strauss vasculitis. Eur Respir J 9:175–177
Pawlik E, Mahler H, Hartung B et al (2015) Drug-related death: adulterants from cocaine preparations in lung tissue and blood. Forensic Sci Int 249:294–303. doi:10.1016/j.forsciint.2015.02.006
Pearson T, Bremmer M, Cohen J, Driscoll M (2012) Vasculopathy related to cocaine adulterated with levamisole: a review of the literature. Dermatol Online J 18:1
Pellegrini D, Young P, Grosso V et al (2013) [Agranulocytosis induced by levamisole in association to cocaine]. Medicina (B Aires) 73:464–466.
Reid JM, Kovach JS, O’Connell MJ et al (1998) Clinical and pharmacokinetic studies of high-dose levamisole in combination with 5-fluorouracil in patients with advanced cancer. Cancer Chemother Pharmacol 41:477–484. doi:10.1007/s002800050770
Rongioletti F, Ghio L, Ginevri F et al (1999) Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol 140:948–951. doi:10.1046/j.1365-2133.1999.02833.x
Scheinfeld N, Rosenberg JD, Weinberg JM (2004) Levamisole in dermatology. Am J Clin Dermatol 5:97–104. doi:10.2165/00128071-200405020-00004
Shu YZ, Kingston DG, Van Tassell RL, Wilkins TD (1991) Metabolism of levamisole, an anti-colon cancer drug, by human intestinal bacteria. Xenobiotica 21:737–750. doi:10.3109/00498259109039513
Silvestri E, Emmi G, D’Elios MM et al (2011) Pulmonary hemorrhage: not only vasculitis. Intern Emerg Med 6:577–580. doi:10.1007/s11739-011-0655-y
Spector S, Munjal I, Schmidt DE (1998) Effects of the immunostimulant, levamisole, on opiate withdrawal and levels of endogenous opiate alkaloids and monoamine neurotransmitters in rat brain. Neuropsychopharmacology 19:417–427. doi:10.1016/S0893-133X(98)00034-7
Symoens J, Veys E, Mielants M, Pinals R (1978) Adverse reactions to levamisole. Cancer Treat Rep 62:1721–1730
Szeto C-C, Gillespie KM, Mathieson PW (2000) Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance. Immunology 100:217–224. doi:10.1046/j.1365-2567.2000.00042.x
Tallarida CS, Egan E, Alejo GD et al (2014) Levamisole and cocaine synergism: a prevalent adulterant enhances cocaine’s action in vivo. Neuropharmacology 79:590–595. doi:10.1016/j.neuropharm.2014.01.002
Thompson JS, Herbick JM, Klassen LW et al (1980) Studies on levamisole-induced agranulocytosis. Blood 56:388–396
Tran H, Tan D, Marnejon TP (2013) Cutaneous vasculopathy associated with levamisole-adulterated cocaine. Clin Med Res 11:26–30. doi:10.3121/cmr.2012.1085
Trautmann F, Kilmer B, Turnbull P (2013) Further insights into aspects of the EU illicit drugs market. Publications Office of the European Union, Luxemburg. doi:10.2838/92919
Tsai M-H, Yang J-H, Kung S-L, Hsiao Y-P (2013) Levamisole-induced myopathy and leukocytoclastic vasculitis: a case report and literature review. Dermatol Ther 26:476–480. doi:10.1111/dth.12018
Tseng W, Sutter ME, Albertson TE (2014) Stimulants and the lung. Clin Rev Allergy Immunol 46:82–100. doi:10.1007/s12016-013-8376-9
UNODC (2015) World Drug Report 2015. United Nations, United Nations Office on Drugs and Crime, Vienna, Austria
Van Laar M, Cruts G, Van Ooyen-Houben M et al (2015) The netherlands drug situation 2014. Trimbos institute, Utrecht, The Netherlands
Van Der Veer T, Pennings E, Tervaert JW, Korswagen LA. (2015) Levamisole-contaminated cocaine: a hairy affair. BMJ Case Rep. doi:10.1136/bcr-2015-210970
Vogel CL, Silverman MA, Mansell PW et al (1980) Mechanisms of levamisole-induced granulocytopenia in breast cancer patients. Am J Hematol 9:171–183
Woestenborghs R, Michielsen L, Heykants J (1981) Determination of levamisole in plasma and animal tissues by gas chromatography with thermionic specific detection. J Chromatogr 224:25–32
Wolford A, McDonald TS, Eng H et al (2012) Immune-mediated agranulocytosis caused by the cocaine adulterant levamisole: a case for reactive metabolite(s) involvement. Drug Metab Dispos 40:1067–1075. doi:10.1124/dmd.112.045021
Woolverton WL, Massey BW, Winger G et al (1994) Evaluation of the abuse liability of aminorex. Drug Alcohol Depend 36:187–192
Xu N, Zhou W, Li S et al (2009) Clinical and MRI characteristics of levamisole-induced leukoencephalopathy in 16 patients. J Neuroimag 19:326–331. doi:10.1111/j.1552-6569.2008.00344.x
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brunt, T.M., van den Berg, J., Pennings, E. et al. Adverse effects of levamisole in cocaine users: a review and risk assessment. Arch Toxicol 91, 2303–2313 (2017). https://doi.org/10.1007/s00204-017-1947-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-017-1947-4